Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actionsMónica Imbernón, Vincent Prévot, Caroline Bonner et al.|Cell Metabolism|2022Cited by 118
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver diseaseOveis Jamialahmadi, Stefano Romeo, Antonio De Vincentis et al.|Nature Medicine|2024Cited by 100
TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individualsOlivier Le Bacquer, François Pattou|Diabetologia|2012Cited by 72
mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cellsOlivier Le Bacquer, François Pattou|Journal of Endocrinology|2012Cited by 36
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin ReleaseChiara Saponaro, Caroline Bonner, Valéry Gmyr et al.|Cell Reports|2019Cited by 35